| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 138,563 | 150,197 | 179,540 | 210,920 | | Cost of Revenue | 100,736 | 109,469 | 153,327 | 179,751 | | | Gross Profit | 37,827 | 40,728 | 26,213 | 31,169 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 23,257 | 21,308 | 32,668 | 14,940 | | Non Recurring |
-
|
-
| (8,635) | 159 | | Others | 28 |
-
| 371 | (292) | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 14,542 | 19,420 | 1,809 | 16,362 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 432 | 1,345 | 5,500 | (7,409) | | Earnings Before Interest And Taxes | 14,974 | 20,765 | 7,309 | 8,953 | | Interest Expense | 1,028 | 1,911 | 5,018 | 2,643 | | Income Before Tax | 13,946 | 18,854 | 2,291 | 6,310 | | Income Tax Expense | 5,451 | 7,349 | (1,041) | 2,388 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 8,743 | 11,745 | 3,572 | 4,157 | | | Non-recurring Events | | Discontinued Operations | (13) | (2) |
-
| 4 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 8,730 | 11,743 | 3,572 | 4,161 | | Preferred Stock And Other Adjustments |
-
| (306) |
-
|
-
| | | Net Income Applicable To Common Shares | $8,730 | $11,437 | $3,572 | $4,161 |
|
0.06% Nasdaq 
Income Statement
